ATNF 180 Life Sciences Corp

Price (delayed)

$1.82

Market cap

$1.55M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$52.59

Enterprise value

$630,306

180 Life Sciences Corp. is a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined ...

Highlights

ATNF's EPS has surged by 86% year-on-year and by 80% since the previous quarter

180 Life Sciences's net income has surged by 51% QoQ and by 49% YoY

ATNF's debt has surged by 197% since the previous quarter but it is down by 21% year-on-year

180 Life Sciences's equity has plunged by 101% YoY but it has increased by 14% from the previous quarter

The quick ratio has dropped by 68% year-on-year and by 29% since the previous quarter

Sector: Healthcare

Industry: Biotechnology

Website: http://180lifesciences.com

Peers: OPTN OPK ORGO

Key stats

What are the main financial stats of ATNF

Market

Shares outstanding

852,772

Market cap

$1.55M

Enterprise value

$630,306

Valuations

Price to earnings (P/E)

N/A

Price to book (P/B)

N/A

Price to sales (P/S)

N/A

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

N/A

Earnings

Revenue

EBIT

-$22.24M

EBITDA

-$22.13M

Free cash flow

-$10.92M

Per share

EPS

-$52.59

Free cash flow per share

-$28.81

Book value per share

-$0.32

Revenue per share

TBVPS

$9.6

Balance sheet

Total assets

$5.26M

Total liabilities

$5.39M

Debt

$1.05M

Equity

-$127,733

Working capital

-$1.42M

Liquidity

Debt to equity

-8.25

Current ratio

0.72

Quick ratio

0.39

Net debt/EBITDA

0.04

Margins

EBITDA margin

N/A

Gross margin

N/A

Net margin

N/A

Operating margin

N/A

Efficiency

Return on assets

-205.5%

Return on equity

-587.2%

Return on invested capital

-1,346.9%

Return on capital employed

-11,297.2%

Return on sales

N/A

Dividend

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

ATNF stock price

How has the 180 Life Sciences stock price performed over time

Intraday

-4.21%

1 week

-4.71%

1 month

-34.3%

1 year

56.9%

YTD

-55.13%

QTD

-21.89%

Financial performance

How have 180 Life Sciences's revenue and profit performed over time

Revenue

Gross profit

Operating income

-$13.48M

Net income

-$19.94M

Gross margin

N/A

Net margin

N/A

180 Life Sciences's net income has surged by 51% QoQ and by 49% YoY

180 Life Sciences's operating income has increased by 25% YoY and by 24% QoQ

Growth

What is 180 Life Sciences's growth rate over time

Valuation

What is 180 Life Sciences stock price valuation

P/E

N/A

P/B

N/A

P/S

N/A

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

N/A

ATNF's EPS has surged by 86% year-on-year and by 80% since the previous quarter

180 Life Sciences's equity has plunged by 101% YoY but it has increased by 14% from the previous quarter

Efficiency

How efficient is 180 Life Sciences business performance

180 Life Sciences's ROIC has plunged by 148% YoY and by 21% from the previous quarter

The company's return on assets has shrunk by 122% YoY but it rose by 32% QoQ

180 Life Sciences's return on equity has increased by 9% QoQ

Dividends

What is ATNF's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for ATNF.

Financial health

How did 180 Life Sciences financials performed over time

The company's total assets is 2.4% lower than its total liabilities

The company's total assets has shrunk by 73% YoY but it rose by 6% QoQ

The quick ratio has dropped by 68% year-on-year and by 29% since the previous quarter

ATNF's debt has surged by 197% since the previous quarter but it is down by 21% year-on-year

180 Life Sciences's equity has plunged by 101% YoY but it has increased by 14% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.